scholarly article | Q13442814 |
P356 | DOI | 10.1080/00332747.1992.11024572 |
P698 | PubMed publication ID | 1557469 |
P2093 | author name string | I. R. Falloon | |
P2860 | cites work | Is schizophrenia disappearing? | Q57403542 |
Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation | Q34285453 | ||
Stages of onset of schizophrenic psychosis | Q40175491 | ||
Low dose fluphenazine decanoate in maintenance treatment of schizophrenia | Q40298512 | ||
Prodromal symptoms in primary major depressive disorder | Q48895154 | ||
Decreasing first-admission rates of schizophrenia among males in Denmark from 1970 to 1984. Changing diagnostic patterns? | Q50548620 | ||
Psychophysiological dysfunctions in the developmental course of schizophrenic disorders. | Q52276698 | ||
A comparative trial of pharmacologic strategies in schizophrenia. | Q54132495 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
schizophrenic psychology | Q69941090 | ||
P304 | page(s) | 4-15 | |
P577 | publication date | 1992-02-01 | |
P1433 | published in | Psychiatry | Q15760563 |
P1476 | title | Early intervention for first episodes of schizophrenia: a preliminary exploration | |
P478 | volume | 55 |
Q90752929 | 'At risk mental state' clinics for psychosis - an idea whose time has come - and gone! |
Q50698703 | A 'navigator' model in emerging mental illness? |
Q78726349 | A decade of debate on early intervention in psychosis: a systematic review of screening criteria |
Q33415727 | Adolescence and schizophrenia |
Q38084211 | Antipsychotic interventions in prodromal psychosis: safety issues |
Q40771364 | Can we improve the diagnostic efficiency and predictive power of prodromal symptoms for schizophrenia? |
Q34701054 | Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial. |
Q41376137 | Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101. |
Q47429226 | Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain. |
Q64095132 | Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress |
Q24243986 | Early Intervention for psychosis |
Q24248672 | Early Intervention for psychosis |
Q33948803 | Early detection and intervention in first-episode schizophrenia: a critical review |
Q39460348 | Early intervention and evaluation for adult-onset psychosis: the JCEP study rationale and design. |
Q24236296 | Early intervention for psychosis |
Q22242332 | Early intervention in patients at ultra high risk of psychosis: benefits and risks |
Q51950564 | Early intervention in schizophrenia: a critique. |
Q34095720 | Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders |
Q37075761 | Ethical concerns in schizophrenia research: looking back and moving forward |
Q34085415 | Ethics and early intervention in psychosis: keeping up the pace and staying in step |
Q38895381 | Family Interventions for Schizophrenia and the Psychoses: A Review |
Q57738646 | Früherkennung und Frühintervention der Schizophrenie |
Q33585800 | Improving outcome in schizophrenia: the case for early intervention |
Q44984345 | Is a national framework for implementing early psychosis services necessary? Results of a survey of Australian mental health service directors |
Q35102462 | Is earlier better? At the beginning of schizophrenia: timing and opportunities for early intervention |
Q41817312 | Is pre-psychotic intervention of schizophrenia realistic ? |
Q41712954 | Is pre-psychotic intervention realistic in schizophrenia and related disorders? |
Q51967984 | Long delays in seeking treatment for schizophrenia. |
Q36420469 | MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms |
Q40954844 | New directions in the prevention and treatment of schizophrenia: a biological perspective |
Q77482059 | New views on the course and treatment of schizophrenia |
Q40578526 | PROD-screen--a screen for prodromal symptoms of psychosis. |
Q33844294 | Portland identification and early referral: a community-based system for identifying and treating youths at high risk of psychosis |
Q35847530 | Preferences for different insomnia treatment options in people with schizophrenia and related psychoses: a qualitative study |
Q74292467 | Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis |
Q36058891 | Prevention of schizophrenia: can it be achieved? |
Q34776827 | Prevention of the first episode of psychosis |
Q58410416 | Prodromal symptoms of schizophrenia in first-episode psychosis: Prevalence and specificity |
Q51876670 | Prospective outcome of early intervention for individuals at ultra-high-risk for psychosis. |
Q34322848 | Psychosis treatment prior to psychosis onset: ethical issues |
Q40568751 | Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome |
Q34322854 | Rationale for the study of early intervention |
Q37979228 | Recent developments in family psychoeducation as an evidence-based practice |
Q34203122 | Reduction in incidence of hospitalizations for psychotic episodes through early identification and intervention |
Q51948707 | Self‐reported psychotic experiences in the general population: a valid screening tool for DSM‐III‐R psychotic disorders? |
Q36688885 | Service Profile of Youths with Schizophrenia-Spectrum Diagnoses |
Q35950862 | Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis |
Q34061090 | Stress in schizophrenia: an integrative view |
Q33881117 | Subthreshold symptoms and vulnerability indicators (e.g., eye tracking dysfunction) in schizophrenia |
Q33788253 | Symptom assessment in schizophrenic prodromal states |
Q90796885 | The DSM-5 proposal for attenuated psychosis syndrome: a history |
Q39270119 | The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe |
Q29542112 | The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis |
Q57998248 | The Pace Clinic: Development of a Clinical Service for Young People at High Risk of Psychosis |
Q34101213 | The continuity of psychotic experiences in the general population. |
Q47811747 | The delaying effect of stigma on mental health help-seeking in Sri Lanka |
Q52007219 | The initial prodrome in psychosis: descriptive and qualitative aspects. |
Q38568466 | The introduction of an early warning signs journal in an adolescent inpatient unit |
Q57998245 | The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey |
Q52880770 | The reliability of DSM-III prodromal symptoms in first-episode psychotic patients. |
Q38074729 | The ultra-high risk concept-a review. |
Q34417104 | The varied outcomes of schizophrenia |
Q35236583 | Treating early psychosis: who, what, and when? |
Q71710406 | Treatment of schizophrenia |
Q42072050 | Treatment timing vs treatment type in first-episode psychosis: a paradigm shift in strategy and effectiveness |
Q34571739 | Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study |
Q34113069 | Use of quantitative rating scales to assess outcome in schizophrenia prevention studies |
Q40617995 | Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome |
Q34742559 | Vulnerability to schizophrenia and psychotherapeutic treatment of schizophrenic patients: towards an integrated view |
Q51560812 | Young people at risk of psychosis: a user-led exploration of interpersonal relationships and communication of psychological difficulties. |
Search more.